Table 6.
Evaluation for unmeasured confounding between SLNB groups by E-value analysis.
Analysis | 1-Year overall survival | 3-Year overall survival |
---|---|---|
Crude analysis—E value | 3.60 | 2.24 |
Multivariable analysis—E value | 2.86 | 1.85 |
Propensity-score analyses | ||
With inverse probability weighting—E value | 3.09 | 1.58 |
With matching—E value | 3.16 | 1.88 |
The larger the E-value, the lower the probability that an unmeasured confounder was to explain the entirety of the treatment effect.